# Forge Biologics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/forge-biologics

- Industry: Biotechnology
- Headquarters: Grove City, US
- Website: www.forgebiologics.com
- Total disclosed funding: $250M
- Latest round: Series C (Sep 12, 2022)
- Investors on record: 7

## About

Based in Ohio, US, and founded in 2020, Forge Biologics, Inc. offers end-to-end manufacturing services of gene therapy for patients with genetic diseases. The company was co-founded by Erandi De Silva, Jaysson Eicholtz, and Timothy J Miller. In November 2023, Ajinomoto Co., Inc. acquired Forge Biologics, Inc.. from Drive Capital, Aisling Capital, MidCap Financial, Surveyor Capital, RA Capital, Perceptive Advisors, Octagon Capital Investments, and Marshall Wace for USD 620 million. Upon completion of the transaction which will be by the end of 2023, Forge Biologics, Inc. will become a subsidiary of Ajinomoto Co., Inc.

The company offers gene therapy manufacturing and therapeutics development to accelerate and develop medicines for rare genetic diseases. Forge Biologics, Inc. offers end-to-end manufacturing and development services to launch gene therapy programs from pre-clinical stage, clinical, and commercial manufacturing. The company works with pharmaceutical companies, by offering novel therapies for genetic diseases.

Ajinomoto Co., Inc.'s acquisition will enable Forge Biologics, Inc. to further develop its capabilities and platform and expand globally.

## Funding rounds

- Series C, Sep 12, 2022, $90M — Aisling Capital, Drive Capital
- Series B, Apr 29, 2021, $120M — Marshall Wace, RA Capital Management, Drive Capital, Perceptive Advisors, Surveyor Capital, Octagon Capital Investments
- Series A, Jul 21, 2020, $40M — Drive Capital, Perceptive Advisors

## Investors

- Drive Capital (https://capitalatlas.ai/funds/drive-capital) — Series A, Series B, Series C
- Perceptive Advisors (https://capitalatlas.ai/funds/perceptive-advisors) — Series A, Series B
- Marshall Wace (https://capitalatlas.ai/funds/marshall-wace) — Series B
- RA Capital Management (https://capitalatlas.ai/funds/ra-capital-management) — Series B
- Surveyor Capital — Series B
- Octagon Capital Investments (https://capitalatlas.ai/funds/octagon-capital-investments) — Series B
- Aisling Capital (https://capitalatlas.ai/funds/aisling-capital) — Series C